Track the market's highs and lows with our comprehensive view of top volume and top value in stocks. Get key insights at a glance!
By Volume
Vodafone Idea
Telecomm-Servic...
03 May 2024
B H E L
Capital Goods -...
03 May 2024
NHPC Ltd
Power Generatio...
03 May 2024
GTL Infra.
Telecomm Equipm...
03 May 2024
By Value
B H E L
Capital Goods -...
03 May 2024
Reliance Indust...
Refineries
03 May 2024
Coal India
Mining & Minera...
03 May 2024
Offer Related Information Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share ("Offer Price") aggregating to Rs. [*] crores, comprising an offer for sale of up to 3,705,443 equity shares aggregating to Rs. [*] crores by Ramesh Juneja, up to 3,505,149 equity shares aggregating to Rs. [*] crores by Rajeev Juneja, up to 2,804,119 equity shares aggregating to Rs. [*] crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), up to 17,405,559 equity shares aggregating to Rs. [*] crores by Cairnhill Cipef Limited, up to 2,623,863 equity shares aggregating to Rs. [*] crores by Cairnhill Cgpe Limited, up to 9,964,711 equity shares aggregating to Rs. [*] crores by Beige Limited and up to 50,000 equity shares aggregating to Rs. [*] crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. Price Band: Rs. 1026 to Rs. 1080 per equity share of the face value of Re. 1 each. The Floor price is 1026 times and the cap price is 1080 times the face value of the equity shares. Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.Offer Related Information Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share ("Offer Price") aggregating to Rs. [*] crores, comprising an offer for sale of up to 3,705,443 equity shares aggregating to Rs. [*] crores by Ramesh Juneja, up to 3,505,149 equity shares aggregating to Rs. [*] crores by Rajeev Juneja, up to 2,804,119 equity shares aggregating to Rs. [*] crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), up to 17,405,559 equity shares aggregating to Rs. [*] crores by Cairnhill Cipef Limited, up to 2,623,863 equity shares aggregating to Rs. [*] crores by Cairnhill Cgpe Limited, up to 9,964,711 equity shares aggregating to Rs. [*] crores by Beige Limited and up to 50,000 equity shares aggregating to Rs. [*] crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. Price Band: Rs. 1026 to Rs. 1080 per equity share of the face value of Re. 1 each. The Floor price is 1026 times and the cap price is 1080 times the face value of the equity shares. Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.